Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 21, 2013; 19(7): 1104-1110
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1104
Published online Feb 21, 2013. doi: 10.3748/wjg.v19.i7.1104
Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure
Xue-Zhang Duan, Fang-Fang Liu, Jing-Jing Tong, Hao-Zhen Yang, Jing Chen, Xiao-Yan Liu, Shao-Jie Xin, Jin-Hua Hu, Liver Failure Treatment and Research Center, Beijing 302 Hospital, Beijing 100039, China
Yuan-Li Mao, Center for Clinical Laboratory, Beijing 302 Hospital, Beijing 100039, China
Author contributions: Duan XZ and Yang HZ analyzed the data; Duan XZ and Hu JH wrote the paper; Duan XZ and Hu JH designed the study; Liu FF and Tong JJ collected the data; Mao YL helped to measure the biochemical parameters and peripheral CD34-positive cells; Chen J, Liu XY and Xin SJ followed up the patients.
Supported by National Natural Science Foundation of China, No. 81171641; the Army Medical and Health Scientific Research Fund of China, No. 06H057
Correspondence to: Jin-Hua Hu, Associate Professor, Liver Failure Treatment and Research Center, Beijing 302 Hospital, No. 100, the 4th Ring Road,Beijing 100039, China. hjh@medmail.com.cn
Telephone: +86-10-66933434 Fax: +86-10-63879339
Received: November 5, 2012
Revised: January 8, 2013
Accepted: January 17, 2013
Published online: February 21, 2013
Revised: January 8, 2013
Accepted: January 17, 2013
Published online: February 21, 2013
Core Tip